Locus 119: SLC5A11 (16p12.1)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs4787294 |
scyllo-inositol |
A/T |
6119 |
0.93 |
0.075 (0.008) |
9.64·10-21 |
show |
| rs4788439 |
myo-inositol |
T/C |
7354 |
0.08 |
-0.027 (0.004) |
6.59·10-13 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs4787294 |
| Chromosomal location | Chr16: 24,909,851 (16p12.1) |
| Gene (distance) | SLC5A11 (79,407) |
| Predicted causal gene | SLC5A11 |
| Gene/protein classification | - |
| Metabolite (Pathway) | scyllo-inositol (Inositol metabolism; Lipid) |
| Biochemical locus-metabolite relationship | SLC5A11 encodes a sodium/myo-inositol transporter (SMIT2) which can also transport scyllo-inostiol [21887366] |
| eQTL associations | SLC5A11 (F) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL1744524 |
| Drug information |
Compounds with low activity in ChEMBL
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

